Related Experiment Video
Updated: Dec 13, 2025

07:23
Optimization of the Retinal Vein Occlusion Mouse Model to Limit Variability
Published on: August 6, 2021
3.1K
Measuring Contrast Sensitivity Function With Active Learning in Retinal Vein Occlusion: A New Endpoint of Visual
Ophthalmic Surgery, Lasers & Imaging Retina
|July 25, 2020
Summary
Contrast sensitivity function (CSF) is significantly reduced in patients with retinal vein occlusion (RVO). This visual function testing offers potential for clinical trials and practice.
Area of Science:
- Ophthalmology
- Visual Neuroscience
- Medical Imaging
Background:
- Retinal vein occlusion (RVO) can impact visual function.
- Characterizing contrast sensitivity function (CSF) in RVO patients is crucial for understanding disease impact.
- Novel computerized testing offers advanced methods for CSF assessment.
Purpose of the Study:
- To characterize contrast sensitivity function (CSF) in patients with retinal vein occlusion (RVO).
- To compare CSF in RVO patients with age-matched controls using advanced CS testing.
- To evaluate the utility of CSF as a visual function endpoint.
Main Methods:
- Prospective measurement of CSF in RVO patients and controls using the Manifold Contrast Vision Meter.
- Quantitative CSF testing included area under the Log CSF (AULCSF), contrast acuity (CA), and CS thresholds at various spatial frequencies.
- Sub-analysis performed on RVO eyes with good visual acuity (VA ≥ 20/30).
Main Results:
- Significantly reduced mean AULCSF and contrast acuity in RVO eyes compared to controls (P < .0001).
- Contrast sensitivity loss was most prominent at 6.0 cycles per degree (cpd) in the RVO group.
- Reduced CSF was observed even in RVO eyes with good visual acuity (P = .008).
Conclusions:
- Contrast sensitivity function is significantly reduced in eyes with retinal vein occlusion.
- CSF measurement is a promising visual function endpoint.
- CSF testing has potential applications in clinical practice and future clinical trials for RVO.

